用 0.005%他克莫司滴眼液治疗过敏性鼻结膜炎患者的症状缓解情况

medRxiv - Ophthalmology Pub Date : 2024-05-01 DOI:10.1101/2024.04.30.24306626

S. Sladek, N. Unger-Manhart, C. Siegl, H. Dellago, P. Zieglmayer, P. Lemell, M. Savli, R. Zieglmayer, W. Geitzenauer, M. Laengauer, E. Prieschl-Grassauer

{"title":"用 0.005%他克莫司滴眼液治疗过敏性鼻结膜炎患者的症状缓解情况","authors":"S. Sladek, N. Unger-Manhart, C. Siegl, H. Dellago, P. Zieglmayer, P. Lemell, M. Savli, R. Zieglmayer, W. Geitzenauer, M. Laengauer, E. Prieschl-Grassauer","doi":"10.1101/2024.04.30.24306626","DOIUrl":null,"url":null,"abstract":"<strong>Purpose</strong> This randomized, placebo-controlled, crossover, double-blind, single site trial was aimed to evaluate efficacy and safety of Tacrosolv, a novel eye drop solution containing solubilized tacrolimus, in adult participants with grass pollen induced allergic conjunctivitis.","PeriodicalId":501390,"journal":{"name":"medRxiv - Ophthalmology","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution\",\"authors\":\"S. Sladek, N. Unger-Manhart, C. Siegl, H. Dellago, P. Zieglmayer, P. Lemell, M. Savli, R. Zieglmayer, W. Geitzenauer, M. Laengauer, E. Prieschl-Grassauer\",\"doi\":\"10.1101/2024.04.30.24306626\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Purpose</strong> This randomized, placebo-controlled, crossover, double-blind, single site trial was aimed to evaluate efficacy and safety of Tacrosolv, a novel eye drop solution containing solubilized tacrolimus, in adult participants with grass pollen induced allergic conjunctivitis.\",\"PeriodicalId\":501390,\"journal\":{\"name\":\"medRxiv - Ophthalmology\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.04.30.24306626\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.04.30.24306626","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的这项随机、安慰剂对照、交叉、双盲、单点试验旨在评估 Tacrosolv（一种含有溶解他克莫司的新型滴眼液）对草花粉引起的过敏性结膜炎成年患者的疗效和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution

Purpose This randomized, placebo-controlled, crossover, double-blind, single site trial was aimed to evaluate efficacy and safety of Tacrosolv, a novel eye drop solution containing solubilized tacrolimus, in adult participants with grass pollen induced allergic conjunctivitis.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

medRxiv - Ophthalmology

自引率

0.00%

发文量